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INTRODUCTION 
Diabetes mellitus is a common cause of pyelonephritis. Patients with 
diabetes mellitus have an increased incidence of pyelonephritis compared to 
non-diabetics. Bilateral pyelonephritis is more common in diabetics, which 
predisposes them to more severe infections and greater complications. 
Pyelonephritis in diabetics can present as emphysematous or non-
emphysematous pyelonephritis. 
 
Non-emphysematous pyelonephritis is a common UTI encountered in 
diabetic patients; may present in patients with good control of blood sugars 
also. Emphysematous pyelonephritis is a necrotizing infection of the renal 
parenchyma with presence of gas in the renal parenchyma, collecting system 
and perinephric tissue. Prevalence of diabetes in patients with emphysematous 
pyelonephritis ranges from 53-90%. Conventional treatment of emphysematous 
pyelonephritis is parenteral antibiotics with percutaneous/ surgical drainage and 
nephrectomy. Emphysematous pyelonephritis results in high morbidity and 
mortality, particularly if blood sugars are poorly controlled and diagnosis and 
treatment is delayed. 
 
A high index of suspicion and early imaging studies are required in 
diabetic patients presenting with pyelonephritis to diagnose emphysematous 
pyelonephritis, especially if blood sugars are poorly controlled.
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AIMS AND OBJECTIVES 
 
To analyse the clinical features, microbiological profile, prognostic factors and 
treatment outcome of acute pyelonephritis in Type 2 diabetes mellitus patients. 
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REVIEW OF THE LITERATURE 
 
Urinary tract infections are due to invasion and multiplication of 
microorganisms especially bacteria in the urinary tract, leading on to a wide 
range of clinical syndromes: 
 –urethritis (inflammation of urethra), 
-prostatitis (inflammation of prostate),  
-cystitis (inflammation of bladder), 
-epididymitis (inflammation of epididymis),  
-acute and chronic pyelonephritis (inflammation of the kidneys). 
Infection can spread to involve the surrounding tissues resulting in 
perinephric abscess and spread to the bloodstream. 
The incidence of urinary tract infection is very common in women of 
reproductive age group. Around 10–20% of women will experience 
symptomatic urinary tract infection at least once in their lifetime. Adult men 
suffer from UTI less common than women but if present usually it is 
complicated and related to abnormalities of the urinary tract, rarely, some 
infections can occur spontaneously in otherwise healthy young men. 
Incidence of Urinary tract infection increases with age for both sexes. It 
is estimated that 10% of men and 20% of women over the age of 65 years 
would have asymptomatic bacteriuria. The diagnosis of urinary tract infection 
is relatively difficult in older people, who are more prone to have 
asymptomatic bacteriuria. 
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                                      TABLE 1.1: Categories of UTI in adults 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNCOMPLICATED UTI 
 Uncomplicated UTI occurs in healthy postmenopausal women 
who do not have genitourinary abnormalities and diabetic women without 
nephropathy or neurologic bladder impairment40. A urinary tract infection is 
usually manifested by a combination of clinical features and the presence of 
bacteriuria. In Asymptomatic bacteriuria, there will be presence of bacteriuria 
without clinical symptoms and signs35.Symptomatic bacteriuria refers to the 
clinical symptoms and signs which have occurred due to the presence of 
bacteria in urine. 
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TABLE1.2: Risk factors for urinary tract infections 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLICATED UTI 
 Complicated UTI is an infection of the urinary tract in which the 
efficacy of antibiotics is reduced because of the presence of one or more of the 
following: 
 Structural abnormalities of the urinary tract 
 Functional abnormalities of the urinary tract 
 Metabolic abnormalities predisposing to UTIs 
 Unusual pathogens 
 Recent antibiotic use 
 Recent urinary tract instrumentation.42 
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Table1.3: Abnormalities of the urinary tract that may be 
associated with complicated UTI 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORGANISMS CAUSING UTI 
The commonly encountered organisms are gram negative 
bacteria, few gram positive cocci. Unusual pathogens include 
mycobacteria, yeasts and fungi, and opportunistic pathogens like 
Corynebacterium urealyticum. 
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                               Table 1.4:1   
 
PYELONEPHRITIS 
Pyelonephritis, from the Greek "pyelo" (pelvis), "nephros" (kidney), and 
"-itis" (inflammation), describes a severe infectious inflammatory disease of 
the renal parenchyma, calices, and pelvis that can be acute, recurrent, or 
chronic33.Pyelonephritis is a less common manifestation of acute 
uncomplicated urinary tract infection than is cystitis. The ratio of 
pyelonephritis to cystitis episodes is reported to be 18:1 and 29:1 in women 
with recurrent infection2.The highest incidence is among young women aged 
20 to 30 years. 
 Pyelonephritis is associated with substantially greater morbidity, 
hospitalization is required for as many as 20% of affected non-pregnant 
women. Severe manifestations such as sepsis syndrome are uncommon. Acute 
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pyelonephritis complicates 1% to 2% of pregnancies, often occurring at the end 
of the second trimester or early in the third trimester. Preterm labour and 
delivery may occur and lead to poor foetal outcomes, as with any febrile illness 
in later pregnancy3.Acute non-obstructive pyelonephritis is rarely a direct cause 
of renal failure. In the few reports of renal failure attributed to pyelonephritis, 
patients were elderly4or had comorbid conditions such as diabetes or HIV 
infection5. 
 Acute pyelonephritis is typically a clinical diagnosis based on 
signs and symptoms of flank pain, tenderness, and fever with accompanying 
laboratory findings of leukocytosis, pyuria, positive urine culture, and 
occasionally bacteremia and hematuria. Most cases of acute pyelonephritis 
occur by the ascending route from the bladder and are caused by gram negative 
bacteria. 
PATHOGENESIS 
                                Fig.1.1.Etiopathogenesis of UTI 
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 A familial susceptibility to pyelonephritis has been reported and 
attributed to polymorphisms with decreased expression of CXCR1, an IL-8 
receptor6. Vesicoureteral reflux may contribute, although the ascent of the 
bacteria up the ureter also occurs in its absence. Vesicoureteral reflux is caused 
by the presence of adhesive P fimbria and powerful endotoxins that appear to 
inhibit ureteral peristalsis, thereby creating a functional obstruction. 
 
 Fig.1.2.Grades of Vesico-ureteral reflux 
 E.coli is isolated in 85 to 90% of women who present with acute 
uncomplicated pyelonephritis7.The gram-negative bacteria, most commonly 
Escherichia coli, are transported to renal pelvis, where intra-renal reflux occurs 
and the organisms traverse the calyceal system to the ducts and tubules within 
the renal pyramid. There is a leukocyte response to the bacteria within the 
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tubules. Enzyme release results in destruction of tubular cells with subsequent 
bacterial invasion of the interstitium. The resultant inflammatory response 
involves both the interstitium and tubules. From there, the infection progresses 
and it spreads throughout the pyramid and to the adjacent parenchyma. The 
inflammatory response leads to focal or more diffuse swelling of the kidney. 
Vasoconstriction of the involved arteries and arterioles is noted. Without 
adequate treatment, necrosis of the involved regions and microabscess 
formation occur. These microabscesses may coalesce into larger 
macroabscesses, which tend to be surrounded by a rim of granulation tissue. 
Perinephric abscess results from the rupture of an intra-renal abscess through 
the renal capsule or the leak from an infected and obstructed kidney 
(pyonephrosis). The overall distribution in the kidney is usually patchy or 
lobar, but sometimes it is diffuse. Subsequent scarring of the kidney after 
treatment reflects the magnitude of the infection and tissue destruction that 
occurred. Vesicoureteral reflux is most common in childhood but may occur in 
adults with lower urinary tract infections or neurogenic bladders. 
Hematogenous infection occurs initially in the cortex of the kidney. It 
eventually involves the medulla. It does not tend to be lobar or pyramidal in 
distribution. The areas of involvement are usually round, peripheral, and 
frequently multiple. These infections are usually caused by gram positive 
bacteria, such as Staphylococcus aureus and Streptococcus species. 
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 Blood-borne infection is less common than ascending infections 
and is usually observed in intravenous drug abusers, immune compromised 
patients, or patients with a source of infection outside the kidney, such as heart 
valves or teeth. Most bacterial data are derived from research with Escherichia 
coli, which accounts for 70-90% of uncomplicated UTIs and 21-54% of 
complicated UTIs (i.e. UTIs that are secondary to anatomic or functional 
abnormalities that impair urinary tract drainage; are associated with metabolic 
disorders; or involve unusual pathogens). A subset of E.coli, the uropathogenic 
 E.coli (UPEC), also termed extra-intestinal pathogenic  E.coli  (ExPEC), 
accounts for most clinical isolates from UTIs. UPEC derives commonly from 
the phylogenetic groups B2 and D, which express distinctive O, K, and H 
antigens. UPEC genes encode several postulated virulence factors (VFs), 
including adhesins, siderophores, protectins, and toxins, as well as having the 
metabolic advantage of synthesizing essential substances. Virulence factors 
such as adhesins have specific regions that attach to cell receptor epitopes in a 
lock-and-key fashion. Mannose-sensitive adhesins (usually type 1 fimbriae) are 
present on essentially all E coli. They contribute to colonization (e.g. bladder, 
gut, mouth, vagina) and possibly pathogenesis of infection; however, they also 
attach to polymorphonuclear neutrophils (PMNs), leading to bacterial clearance 
 Mannose-resistant adhesins permit the bacteria to attach to 
epithelial cells, thereby resisting the cleansing action of urine flow and bladder 
emptying. They also allow the bacteria to remain in close proximity to the 
epithelial cell, enhancing the activity of other VFs. The P fimbriae family of 
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adhesins is epidemiologically associated with prostatitis, pyelonephritis (70-
90% of strains), and sepsis. This family of adhesins is associated with less than 
20% of asymptomatic bacteriuria (ABU) strains. The FA/Dr family is 
associated with diarrhoea, UTI, and particularly pyelonephritis in pregnancy. 
The S/F1C family is associated with neonatal meningitis and UTI. 
Siderophores are involved in iron uptake, an essential element for bacteria, and 
possibly adhesion. Protectins and their contributions to virulence include the 
following: 
 Lipopolysaccharide (LPS) coatings: resist phagocytosis 
 Tra T and Iss: resist action of complement 
 Omp T: cleave host defense proteins (eg, immunoglobulins)  
Toxins, which affect various host cell functions, include the following: 
 Alpha-hemolysin 
 Cytotoxic necrotizing factor–1 
 Cytolethal distending toxin 
 Secreted autotransporter toxin 
  No single VF is sufficient or necessary to promote 
pathogenesis. Apparently, multiple VFs are necessary to ensure pathogenesis, 
although adhesins play an important role in epithelial attachment and 
inflammatory response. Evidence suggests that the pathogenesis of 
pyelonephritis takes a 2-step path. First, UPEC attaches to the epithelium and 
triggers an inflammatory response involving at least 2 receptors, 
glycosphingolipid (GSL) and Toll-like receptor 4 (TLR4). In the mouse model, 
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GSL is the primary receptor and TLR4 is recruited and is an important receptor 
for the release of chemokines38. When TLR4 is genetically absent, an 
asymptomatic carrier state develops in the infected mice. Second, as a result of 
the inflammatory response, chemokines (eg, interleukin-8 [IL-8], which is 
chemotactic for PMNs) are released and attach to the neutrophil-activating 
chemokine receptor 1 (CXCR1), allowing PMNs to cross the epithelial barrier 
into the urine. In children prone to pyelonephritis, for example, CXCR1 
expression has been shown to be significantly lower than in control subjects. 
Several other host factors militate against symptomatic UTI41. Phagocytosis of 
bacteria in urine is maximized at pH 6.5-7.5 and osmolality of 485 mOsm; 
values deviating from these ranges lead to significantly reduced or absent 
phagocytosis. Other important factors are the flushing action of urine flow in 
the ureter and bladder, the inhibition of attachment of type 1 fimbriae E coli to 
uroepithelial cells by tubular cell–secreted Tamm-Horsfall protein, and the 
inhibition of attachment by some surface mucopolysaccharides on the 
uroepithelial cells39. 
 
OBSTRUCTION 
 Obstruction is the most important factor. It negates the flushing 
effect of urine flow; allows urine to pool (urinary stasis), providing bacteria a 
medium in which to multiply; and changes intrarenal blood flow, affecting 
neutrophil delivery. Obstruction may be extrinsic or intrinsic. Extrinsic 
obstruction occurs with chronic constipation (particularly in children), prostatic 
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swelling/mass (eg, hypertrophy, infection, cancer), and retroperitoneal mass. 
Intrinsic obstruction occurs with bladder outlet obstruction, cystocele, fungus 
ball, papillary necrosis, stricture, and urinary stones. With increasing size of 
stone, the probability of stone passage decreases while the probability of 
obstruction increases. Nonetheless, stones as small as 2 mm have resulted in 
obstruction, while 8-mm stones have occasionally passed spontaneously36. 
 Infectious stones, urease stones, or triple-phosphate stones 
composed of magnesium ammonium phosphate or struvite and apatite account 
for 10-15% of all urinary stones. They develop secondary to the action of urea-
splitting organisms and can grow rapidly and branch out (ie, staghorn 
calculi).Infectious stones, urease stones, or triple-phosphate stones composed 
of magnesium ammonium phosphate or struvite and apatite account for 10-15% 
of all urinary stones. They develop secondary to the action of urea-splitting 
organisms and can grow rapidly and branch out (ie, staghorn calculi).If left 
untreated, staghorn calculi will destroy the kidney and may cause the death of 
the patient. Complications include azotemia, hydropyonephrosis, perinephric 
abscess, pyelonephritis (severe or end-stage), sepsis, and xanthogranulomatous 
pyelonephritis. Incomplete bladder emptying may be related to medication (eg, 
anticholinergics).  
 The spermicide nonoxynol-9 inhibits the growth of lactobacilli. 
Lactobacilli produce hydrogen peroxide, which protects the vaginal ecosystem 
against pathogens. Frequent sexual intercourse causes local mechanical trauma 
to the urethra in both partners. Atrophic vaginal mucosa in post-menopausal 
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women predisposes to the colonization of urinary tract pathogens and UTIs 
because of the higher pH (5.5 vs 3.8) and the absence of lactobacilli. Bacterial 
prostatitis (acute or chronic) produces bacteriuria, whereas nonbacterial 
prostatitis and pelvic perineal pain syndrome (prostadynia) do not. 
 Unusual organisms include Mycoplasma, Pseudomonas, and 
urea-splitting organisms. Pseudomonas aeruginosa has several mechanisms 
that promote adherence, including alginate, other membrane proteins, pili, and 
surface-associated exo-enzymes. Urea-splitting organisms produce urease, 
which hydrolyzes urea, yielding ammonia, bicarbonate, and carbonate; this 
leads to a more alkaline urine and allows crystal formation (staghorn calculus) 
from the supersaturation of carbonate, apatite and struvite. Staghorn calculi 
continue to grow in size, leading to infection, obstruction, or both.  
Complications of obstruction with superimposed infection include 
hydronephrosis, pyonephrosis, urosepsis, and  xanthogranulomatous 
pyelonephritis. Additionally, the pathogens can sequester in the struvite stones, 
protected from the host’s immune system. Proteus species are the most 
common urea-splitting organisms.  E.coli, Klebsiella, Pseudomonas, 
 and Staphylococcus can also produce urease, however, and are sometimes 
involved in staghorn calculus formation. Pregnancy produces hormonal and 
mechanical changes that predispose the woman to upper urinary traction 
infections. Hydroureter of pregnancy, secondary to both hormonal and 
mechanical factors, manifests as dilatation of the renal pelvis and ureters 
(greater on the left than on the right), with the ureters containing up to 200 mL 
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of urine. Progesterone decreases ureteral peristalsis and increases bladder 
capacity. The enlarging uterus displaces the bladder, contributing to urinary 
stasis.  
 Complicated UTI can result from one or more diverse factors. In 
patients with AIDS, urinary tract infections are quite common. The infections 
are frequently hematogenous with unusual organisms such as Pneumocystis 
carinii, cytomegalovirus, and Mycobacterium avium–intracellulare. The 
infections may also be apparent in other abdominal structures, Such as the 
liver, spleen, and adrenal glands. Diabetes mellitus produces autonomic bladder 
neuropathy, glucosuria, leukocyte dysfunction, microangiopathy, and 
nephrosclerosis; additionally, it leads to recurrent bladder instrumentation 
secondary to the neuropathy.  
Complicated UTIs in patients who have diabetes mellitus include the 
following: 
 Renal and perirenal abscess 
 Emphysematous pyelonephritis 
 Emphysematous cystitis 
 Fungal infections 
 Xanthogranulomatous pyelonephritis 
 Papillary necrosis. 
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Renal Abscess : 
Renal cortical and corticomedullary abscesses and peri-renal abscesses 
occur in 1 to 10 per 10,000 hospital admissions. Patients usually present with 
fever, chills, back or abdominal pain, and costovertebral angle tenderness, but 
they may have no urinary symptoms or findings if the abscess does not 
communicate with the collecting system, as often occurs with a cortical 
abscess. 
Renal abscess formation is more common with hematogenous infection 
than with ascending infection. Bacteremia may be primary (cortical abscess) or 
secondary (corticomedullary or perirenal). 25 to 39% of abscesses are intra-
nephric, 19 to 25% are both intra-nephric and peri-nephric and 42-51% are 
perinephric alone8. 
The clinical presentation may be insidious and nonspecific, especially 
with peri-renal abscess, and the diagnosis may not be made until admission to a 
hospital or at autopsy37. Empiric antibiotic therapy should be broad and cover 
S. aureus and other uropathogens causing complicated UTI and modified once 
urine culture results are known.  
18 
 
 
Fig.1.3. USG showing cavity of a small renal abscess. 
 
A renal cortical abscess (renal carbuncle) is usually caused by S. 
aureus, which reaches the kidney by hematogenous spread. Treatment with 
antibiotics is usually effective, and drainage is not required unless the patient is 
slow to respond. A renal corticomedullary abscess, in contrast, usually results 
from ascending UTI in association with an underlying urinary tract 
abnormality, such as obstructive uropathy or VUR, and is usually caused by 
common uropathogenic species such as E. coli and other gram-negative bacilli. 
Such abscesses may extend deep into the renal parenchyma, perforate the renal 
capsule, and form a perirenal abscess.  
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EMPHYSEMATOUS PYELONEPHRITIS: 
Emphysematous pyelonephritis (EPN) is a severe infection of the renal 
parenchyma that causes gas accumulation in the tissues (9). Gas is localized in 
and around the kidneys in pyelonephritis (10).EPN most often occurs in 
persons with diabetes mellitus, especially women. Its presentation is similar to 
that of acute pyelonephritis, but EPN often has a fulminating course, and can 
be fatal if not recognized and treated promptly. 
  
Historicallly, EPN has been described by terms such as renal 
emphysema and pneumonephritis; Schultz and Klorfein recommended the term 
emphysematous pyelonephritis in 1962. 
 
The infection often has a fulminating course and can be fatal if left 
untreated. However, urinary tract infections are common in persons with 
diabetes, and not all of these infections lead to EPN. The factors that 
predispose to EPN in persons with diabetes may include uncontrolled diabetes, 
high levels of glycosylated hemoglobin, and impaired host immune 
mechanisms. 
 
Fermentation of glucose with carbon dioxide production by the 
pathogens has been proposed as the cause of gas in the tissues. Schainuck et al 
proposed that fermentation products from tissue necrosis produced carbon 
dioxide. Three analyses of the gas content in EPN demonstrated that the major 
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components include nitrogen (60%), hydrogen (15%), carbon dioxide (5%), 
and oxygen (8%). Huang et al concluded that mixed acid fermentation is the 
mechanism of gas production, based on the presence of hydrogen.  
Although carbon dioxide is released by the bacteria, the final tissue 
equilibrium achieved by tissues and gas bubbles determines the final carbon 
dioxide content. Diabetic microangiopathy may also contribute to the slow 
transport of catabolic products and may lead to accumulation of gas. 
Patients typically present with fever (79%), abdominal or flank pain 
(71%), nausea and vomiting (17%), dyspnea (10%), acute renal impairment 
(35%), altered sensorium (19%), shock (29%), and thrombocytopenia (46%). 
Crepitus over the flank area may occur in advanced cases of EPN. 
Pneumaturia is uncommon unless emphysematous cystitis is present. 
Subcutaneous emphysema and pneumomediastinum have also been reported in 
a case of EPN. Comorbidities include alcoholism, malnourishment, renal 
calculi, and diabetic ketoacidosis. A high index of suspicion is important when 
attempting to diagnose emphysematous pyelonephritis (EPN) promptly. 
Recommended laboratory studies and expected results include: 
 Urinalysis - Pyuria, infected urine 
 Complete blood cell count with differential - Leukocytosis with a left 
shift, thrombocytopenia 
 Renal function tests - Elevated creatinine level 
 Blood cultures - Positive 
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Fig1.4. Plain radiograph showing diffuse gas formation throughout  
both  the kidneys  (arrows) and gas dissecting in left retroperitoneal 
space (arrowhead). 
 
PAPILLARY NECROSIS  
More than half of patients who develop papillary necrosis have diabetes, 
almost always in conjunction with a UTI, but the condition also complicates 
sickle cell disease, analgesic abuse, and obstruction. 
 Renal papillae are vulnerable to ischemia because of the sluggish blood 
flow in the vasa recta, and relatively modest ischemic insults may cause 
papillary necrosis. The clinical features are those typical of pyelonephritis. In 
addition, passage of sloughed papillae into the ureter may cause renal colic, 
renal impairment or failure, or obstruction with severe urosepsis. 
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Papillary necrosis in the setting of pyelonephritis is associated with 
pyuria and a positive urine culture. Causative uropathogens are those typical of 
complicated UTI.  
XANTHOGRANULOMATOUS PYELONEPHRITIS: 
Xanthogranulomatous pyelonephritis (XGP), first described by 
Schlagenhaufer in 1916, is a rare, serious, chronic inflammatory disorder of the 
kidneys characterized by destruction and replacement of renal parenchyma by 
granulomatous tissue containing histiocytes and foamy cells11,12. 
 XGP is most commonly associated with Proteus or E.coli.  
Pseudomonas species have also been implicated. The kidney is usually non-
functional. Most cases of XGP involve a diffuse process; however, up to 20% 
are focal. Stones (frequently of staghorn proportions) develop in 80% of 
patients with XGP but are not required to make the diagnosis.  
XGP is often observed in patients with diabetes, immunocompromised 
or both. Abnormal lipid metabolism has also been hypothesized as an etiologic 
factor in individuals with XGP. XGP displays neoplasm-like properties capable 
of local tissue invasion and destruction and has been referred to as a pseudo-
tumour. Adjacent organs, including the spleen, pancreas, or duodenum, may be 
involved. 
Malek and Elder have proposed the following stages of XGP 
involvement  : 
 Kidney 
 Perinephric fat 
 Adjacent retroperitoneal structures 
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The gross appearance of XGP is that of a mass of yellow tissue with 
regional necrosis and hemorrhage, superficially resembling renal cell 
carcinoma. 
 
The pathognomonic microscopic feature is the lipid-laden foamy 
macrophage accompanied by both chronic- and acute-phase inflammatory 
cells. Focal abscesses may be observed. 
The primary mechanisms involved in XGP include nephrolithiasis, 
collecting system obstruction, and infection. No single factor can explain the 
process; rather, an inadequate host response to the acute inflammatory response 
occurs in the obstructed, necrotic kidney. Patients with xanthogranulomatous 
pyelonephritis (XGP) often appear chronically ill. Symptoms include anorexia, 
fever, chills, weight loss, and flank pain. The pain of XGP is not colicky in 
nature; it is usually dull and persistent. 
 XGP is notorious for fistulization. Pyelo-cutaneous and uretero-
cutaneous fistulae have been well described. Other organs are occasionally 
involved in this process, including surrounding viscera (with resulting 
pyeloenteric fistulae). 
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Fig.1.5. Xanthogranulomatous pyelonephritis 
Catheter-Associated Infections: 
The Center for Disease Control and prevention (CDC) and the National 
Healthcare Safety Network (NHSN) define CAUTI as a UTI episode for which 
an indwelling catheter has been placed for >2 days on the date of diagnosis and 
an indwelling catheter was in place on the date of event or the day 
before13.Approximately 15% to 25% of patients in general hospitals have a 
urethral catheter inserted at some time during their stay, and approximately 5% 
to 10% of long-term care facility residents are managed with urethral 
catheterization, in some cases for years.  
 
The incidence of bacteriuria associated with indwelling catheters is 3% 
to 10% per day of catheterization, and the duration of catheterization is the 
most important risk factor for the development of catheter-associated 
bacteriuria.  
Catheter-associated bacteriuria is the most common source of gram 
negative bacteremia in hospitalized patients32. Complications of long-term 
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catheterization (≥30 days) include almost universal bacteriuria, often with 
multiple antibiotic-resistant flora, and (in addition to cystitis, pyelonephritis, 
and bacteremia, as seen with short-term catheterization) frequent febrile 
episodes, catheter obstruction, stone formation associated with urease-
producing uropathogens, and local genitourinary infections. 
 
INVESTIGATIONS IN ACUTE PYELONEPHRITIS: 
URINALYSIS 
URINE CULTURE 
BLOOD CULTURE 
COMPLETE BLOOD COUNT 
ESR /CRP 
RENAL ULTRASONOGRAPHY 
CONTRAST-ENHANCED COMPUTED TOMOGRAPHY (CECT) 
 
  
26 
 
1. URINALYSIS: 
Urinalysis is one of the key tests to evaluate kidney and urinary tract 
disease. 
Acceptable methods of collection are the following: 
a.  Midstream urine voided into a sterile container after careful washing 
(water or saline) of external genitalia (any soap must be rinsed away) 
b.  Urine obtained by single catheterization or suprapubic needle aspiration 
of the bladder 
c.  Sterile needle aspiration of urine from the tube of a closed catheter 
drainage system (do not disconnect tubing to get specimen). 
 
Bacteria and leukocytes are the hallmarks of urinary tract infection, in 
association with superficial transitional epithelial cells and isomorphic 
erythrocytes. Struvite crystals can also be present when the infection is caused 
by urease-producing bacteria, such as U. urealyticum. In patients with renal 
infection, leukocyte casts and casts containing microorganisms may be found. 
The correlation between the urine sediment findings and the urine culture is 
usually good. The finding of WBC casts, signifying infection within the 
tubules, is of primary diagnostic value for both acute and chronic 
pyelonephritis 
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LEUKOCYTE ESTERASE 
The leukocyte esterase dipstick test evaluates the presence of leukocytes 
based on the activity of an indoxyl esterase released from lysed neutrophil 
granulocytes. Leukocyte esterase may be positive when microscopy is negative 
and when leukocytes are lysed, because of low relative density, alkaline pH, or 
a delay in sample handling and examination. 
Nitrites 
The dipstick nitrites test detects bacteria that reduce nitrates to nitrites 
by nitrate reductase activity. This includes most gram negative uropathogenic 
bacteria, but not Pseudomonas, Staphylococcus albus, or Enterococcus.  
URINE CULTURE: 
A urine specimen for culture should be obtained before initiation of 
antimicrobial therapy in every case of suspected pyelonephritis. Urine 
specimens must be cultured promptly within 2 hours or be preserved by 
refrigeration or a suitable chemical additive (e.g., boric acid sodium formate 
preservative). 
The culture will confirm the diagnosis of urinary tract infection and 
identify the specific infecting organism and susceptibilities so that 
antimicrobial therapy can be optimized. In more than 95% of women with 
pyelonephritis, 105 CFU/mL of organisms or more are isolated from the urine 
culture. Most common organisms isolated include gram negative bacilli such as 
Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, Acinetobacter 
species and gram positive cocci such as Staphylococci. 
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Table 1.5: Quantitative counts of bacteria in urine 
 
 
BLOOD CULTURE: 
Bacteremia is identified in 10% to 25% of women presenting with acute 
pyelonephritis if blood cultures are collected routinely. However, the clinical 
utility of routine blood cultures is limited because bacteremia does not alter 
therapy, nor is it predictive of outcome14,15.Thus blood cultures should be 
obtained selectively, usually only if the diagnosis is uncertain or the clinical 
presentation is severe. Growth of the same organism from both blood and urine 
usually confirms a urinary source for the infection. However, bacteria isolated 
from the urine are occasionally attributable to bacteremia from a source outside 
the urinary tract. This may be a result of hematogenous seeding with 
development of renal microabscesses, which is well described for 
Staphylococcus aureus in particular. 
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OTHER BLOOD INVESTIGATIONS: 
Additional investigations recommended for most patients presenting 
with acute pyelonephritis are measurements of peripheral leukocyte count and 
serum creatinine. The leukocyte count is usually elevated and may be useful as 
a parameter to monitor the response to therapy.  
C-reactive protein and procalcitonin levels are elevated in most women 
with acute pyelonephritis2,16,17. An elevated level of C-reactive protein at 
discharge has been associated with prolonged hospitalization and subsequent 
recurrence. The serum procalcitonin level at presentation, however, is not 
predictive of outcome. 
 
IMAGING: 
Imaging is rarely used or needed in the uncomplicated case of acute 
pyelonephritis. It is reserved for patients who are not responding to 
conventional antibiotic treatment, patients with an unclear diagnosis, patients 
with coexisting stone disease and possible obstruction, patients with diabetes 
and poor antibiotic response, and immunocompromised patients. 
 
When the clinical presentation of pyelonephritis is mild or moderate and 
the clinical response after initiation of antimicrobial therapy is prompt, routine 
diagnostic imaging is not indicated18,19. Women whose clinical presentations 
are severe, who fail treatment, or who experience early post-treatment recurrent 
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infection, should undergo prompt imaging to rule out obstruction or abscesses 
and to determine whether intervention is necessary. 
 
Imaging is used to assist in confirming the diagnosis and determining 
the extent of the disease. It is also used in assessing complications of acute 
pyelonephritis, including renal abscess, emphysematous pyelonephritis, and 
perinephric abscess. 
 
ULTRASONOGRAPHY: 
Ultrasonography is often the initial imaging modality because it is safe 
and widely accessible20. The ultrasound examination in women with 
uncomplicated pyelonephritis usually yields normal results, but enlargement 
and edema in one or both kidneys is observed in 20% of patients21. 
 
Ultrasonography is less sensitive or specific for pyelonephritis than is 
either CT or MRI. Imaging study findings that can raise suspicion of EPN 
include the presence of intrarenal gas on renal ultrasonography. 
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Fig.1.6. USG showing focal pyelonephritis 
 
 
CHRONIC PYELONEPHRITIS 
This chronic inflammatory state is usually the result of frequent previous 
inflammatory/infective episodes. The kidney may be small and often has focal 
scarring present. Scar tissue has the appearance of a hyperechoic, linear lesion 
which affects the smooth renal outline and crosses the renal cortex. 
 
RENAL CT: 
ACUTE PYELONEPHRITIS: 
Abnormalities observed on CT are characterized as unilateral or 
bilateral, focal or diffuse, focal swelling or no focal swelling, and renal 
enlargement or no renal enlargement. In addition to renal enlargement and 
oedema, dilation of the collecting system in the absence of obstruction, wedge-
shaped areas of decreased attenuation, and rounded low-attenuation masses 
with delayed enhancement may be observed. 
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CHRONIC PYELONEPHRITIS 
Imaging findings include renal scarring, atrophy, and cortical thinning; 
hypertrophy of residual normal tissue (which may mimic a mass lesion); 
calyceal clubbing secondary to retraction of the papilla from the overlying scar; 
dilatation of the calyceal system; and overall renal asymmetry. 
 
RENAL ABSCESS: 
CT is recommended to establish the diagnosis and location of a renal or 
peri-renal abscess. 
Fig.1.7. CECT shows abscess in the renal medulla (arrowhead) with extension 
into   the perinephric space (arrows) 
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EMPHYSEMATOUS PYELONEPHRITIS: 
Computed tomography (CT) scanning is the definitive imaging 
test for EPN.9,20. 
In 2000, Huang and Tseng modified the staging proposed by 
Michaeli et al, as follows : 
• Class 1 - Gas confined to the collecting system 
• Class 2 - Gas confined to the renal parenchyma alone 
• Class 3A - Perinephric extension of gas or abscess 
• Class 3B - Extension of gas beyond the Gerota fascia 
• Class 4 - Bilateral EPN or EPN in a solitary kidney. 
 
                  Fig.1.8.CECT showing right emphysematous pyelonephritis 
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CT FINDINGS IN PAPILLARY NECROSIS: 
CT is the preferred diagnostic procedure. Radiologic findings include an 
irregular papillary tip; dilated calyceal fornix; extension of contrast material 
into the parenchyma; and a separated crescent-shaped papilla surrounded by 
contrast, called “the ring sign”. 
 
CT IN XANTHOGRANULOMATOUS PYELONEPHRITIS: 
CT scanning is the most useful radiographic technique in evaluating 
xanthogranulomatous pyelonephritis (XGP), although XGP cannot be 
diagnosed solely on the basis of radiographic findings. It identifies the 
abnormality in 74% to 90% of the cases. A CT scan demonstrates a 
heterogenous, non-enhancing mass on a hydronephrotic, non-functioning 
kidney with a central stone.  In higher stage disease, the mass may appear to 
involve adjacent organs. CT scans may also reveal a large staghorn calculus 
within the collecting system. 
MRI shows abnormalities similar to those observed with CT21. 
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Fig.1.9 General algorithm for investigations and management of pyelonephritis 
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The majority of women with uncomplicated pyelonephritis can receive 
treatment as outpatients22. Indications for hospitalization include pregnancy, 
hemodynamic instability, uncertain gastrointestinal absorption or compliance 
with oral therapy, the need to exclude complicating factors such as obstruction 
or abscess, or the necessity of monitoring or treatment of associated medical 
illnesses.  
 
Appropriate supportive management for hypotension, nausea and 
vomiting, and pain control should be initiated promptly. When oral tolerance is 
uncertain because of nausea and vomiting, a strategy frequently used in 
emergency room management is to provide a single parenteral dose of 
ceftriaxone, 1 g, or of gentamicin, 120 mg, followed by oral therapy once 
gastrointestinal symptoms are controlled. Many parenteral antimicrobial 
regimens are effective for pyelonephritis. E. coli strains generally remain 
susceptible to aminoglycosides, and these agents are useful for empirical 
treatment. 
 
Aminoglycosides also have unique efficacy for the treatment of renal 
infection in that they are bound in high concentrations in the renal cortex23. 
Extended-spectrum cephalosporins, such as cefotaxime or ceftriaxone, and 
fluoroquinolones, such as ciprofloxacin and levofloxacin, are other options for 
parenteral therapy24. Ceftriaxone is the preferred empirical regimen for 
pregnant women.  
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Although it is suggested that gentamicin be avoided in pregnancy 
because of potential fetal ototoxicity, excess otologic impairment has not been 
reported in large cohorts of newborn infants stratified by gentamicin exposure 
in utero25. Thus, when cephalosporins cannot be used because of antimicrobial 
resistance or patient intolerance, gentamicin remains an alternate antimicrobial 
for treatment of pregnant women. 
 
A satisfactory clinical response is usually observed by 48 to72 hours 
after initiation of antimicrobial therapy. Oral therapy selected on the basis of 
urine culture results can then be prescribed to complete the antimicrobial 
course34.In most young, non-pregnant women, acute pyelonephritis is 
effectively managed with outpatient oral therapy26,27.  
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      Table.1.6.Antibiotic regimes for pyelonephritis 
 
TREATMENT OF THE COMPLICATIONS: 
 
RENAL ABSCESS: 
Treatment with antimicrobial agents without drainage may be effective 
if the abscess is small and if the underlying urinary tract abnormality can be 
corrected. Aspiration of the abscess may be necessary in some patients, and 
nephrectomy may occasionally be required in patients with diffuse renal 
involvement or with severe sepsis. Perirenal abscesses usually occur in the 
setting of obstruction or other complicating factors and result from ruptured 
intrarenal abscesses, hematogenous spread, or spread from a contiguous 
infection. 
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A previously high mortality rate has been lowered with earlier diagnosis 
and therapy. In contrast to the other types of abscesses, drainage of pus is the 
cornerstone of therapy, and nephrectomy may be indicated28,29,30. 
 
EMPHYSEMATOUS PYELONEPHRITIS: 
Patients with emphysematous pyelonephritis (EPN) are extremely ill and 
need resuscitative measures in the intensive care unit, including oxygen, 
intravenous (IV) fluids, and correction of acid-base imbalances, along with 
glycaemic control. Systolic blood pressure should be maintained above 
100 mm Hg, with fluid or inotropic support if required.  Surgical intervention 
should be performed only after stabilization of the cardiorespiratory status. 
 
Prompt initiation of empiric IV antibiotic therapy is critical. The 
regimen chosen should be broad spectrum, primarily target gram-negative 
bacteria, and take into account individual patient characteristics and local 
patterns of antibiotic resistance. 
 
Conservative treatment using percutaneous drainage/ percutaneous 
nephrostomy31 with antibiotics is indicated as follows: 
- Patients with compromised renal function 
- Early cases associated with gas in the collecting system alone and 
patient is in otherwise in stable condition 
- Class 1 and class 2 EPN 
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-  Class 3 and class 4 EPN - In the presence of fewer than 2 risk factors 
(eg, thrombocytopenia, elevated serum creatinine levels, altered 
sensorium, shock). 
The use of nephrectomy is indicated as follows: 
- Treatment of choice for most patients 
- No access to percutaneous drainage or internal stenting (after patient is 
stabilized) 
- Gas in the renal parenchyma or "dry-type" EPN 
- Possibly bilateral nephrectomy in patients with bilateral EPN 
- Class 3 and class 4 EPN - In the presence of two or more risk factors 
(eg, thrombocytopenia, elevated serum creatinine, altered sensorium, 
shock). 
 
PAPILLARY NECROSIS: 
Broad-spectrum antibiotics are indicated. Papillae obstructing the ureter 
may require removal with a cystoscopic ureteral basket or relief of obstruction 
by insertion of a ureteral stent. 
 
XANTHOGRANULOMATOUS PYELONEPHRITIS: 
Xanthogranulomatous pyelonephritis (XGP) is a surgically managed 
disease that is treated with either nephrectomy or, in rare circumstances, partial 
nephrectomy .Antibiotics are used in all cases, but medical care rarely suffices 
for treatment12 
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MATERIALS AND METHODS 
 
Study Design: Prospective observational study 
Sample Size : 100 patients.  
{ based on formula :  ss = Z2 × p × (1-p) / C2 
                     Where z= z value  
                      p= percentage picking a choice  
           c=confidence interval} 
Statistical methods: 
Values are expressed as mean +/- standard deviation. 
 P < 0.05 was taken as an upper limit of statistical significance. 
Inclusion Criteria: 
-  Patients with diagnosis of acute pyelonephritis (Both emphysematous 
and non-emphysematous) with type 2 diabetes mellitus. 
     - Age >40 years 
Exclusion Criteria: 
Patients with inflammatory conditions other than pyelonephritis, 
including: 
History of trauma, 
Pregnancy,   
Malignancies, 
Other immunosuppressed conditions. 
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Data Collection and methods : 
     -  Acute pyelonephritis said to be present when patient complained of 
fever with chills and rigors, flank pain, nausea and vomiting. 
- USG KUB studies suggestive of pyelonephritis if there was a 
combination of enlarged kidney, presence of collection  and perinephric 
fat stranding. 
- Urine sample collection: Methods of collection are the following: 
a. Midstream urine voided into a sterile container after careful washing 
(water or saline) of external genitalia  
b. Urine obtained by single catheterization or suprapubic needle 
aspiration of the bladder 
c. Sterile needle aspiration of urine from the tube of a closed catheter 
drainage system  
- Urine culture positive:  > 105colony forming units/ml of bacteria found. 
- Glycaemic control-defined as good if HbA1c<7%, moderate if HbA1c 
7-7.5% and poor if HbA1c >7.5%. 
On the basis of CT scan (when necessary), patients with emphysematous 
pyelonephritis can be classified into the following classes: 
 (1)  Class 1: Gas in the collecting system only  
(2)  Class 2: Gas in the renal parenchyma without extension to the extra-renal space  
(3)  Class 3A; Extension of gas or abscess to the perinephric space;  
       Class 3B: Extension of gas or abscess to the pararenal space 
 (4) Class 4: Bilateral EPN or solitary kidney with EPN. 
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Investigations done include Complete Blood Count, urinalysis including 
urine culture and sensitivity, HbA1C, serum creatinine, fasting and 
postprandial blood glucose levels, ultrasound KUB (baseline), CECT-KUB 
(whenever necessary, in case of suspected renal abscess and non-recovering 
pyelonephritis). 
 
Management: 
Patients were treated with antibiotic as per culture sensitivity reports. 
Patients with NEPN were treated with parenteral antibiotics for 1 week 
followed by oral antibiotics for 2 weeks and EPN patients received antibiotics 
for at least 3 weeks. Patients with fungal UTI were initially treated with 
fluconazole for Candida species and amphotericin for non-candida species and 
changed as per culture sensitivity and continued for 2 weeks. Percutaneous 
drainage (PCD) with pigtail or percutaneous nephrostomy tube was inserted 
into pelvis or perirenal space to drain out fluid collection/gas in addition to 
antibiotics. Nephrectomy was carried out in patients refractory to antibiotics, 
PCN and/or clinical deterioration. 
 
Patients were divided into “good” and “poor” outcome groups to 
elucidate the risk factors. The patients who were successfully treated with 
antibiotics alone or with PCN were assigned to “good” outcome group. Those 
who had nephrectomy or died were classified as “poor” outcome group.  
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RESULTS 
. 
Table 2.1: Distribution of study subjects based on gender 
 
GENDER FREQUENCY PERCENT 
Male 48 48.0 
Female 52 52.0 
Total 100 100.0 
 
Fig.2.1: Representation of study subjects based on gender 
 
 
In our study, 48 patients were males and 52 patients were females. 
 
 
48%
52%
GENDER
Male
Female
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Table 2.2: 
Distribution of study subjects based on age group –                                              
[ 41-50yrs, 51-  60yrs, 61-70 yrs, >70 yrs] 
AGE_GROUP FREQUENCY PERCENT 
40-50 Years 25 25.0 
51-60 Years 40 40.0 
61-70 Years 32 32.0 
Above 70 Years 3 3.0 
Total 100 100.0 
 
Fig.2.2: Representation of study subjects based on age group 
 
Around 40% patients were in the age group of 51-60 years, 32% were between 
61-70 years, 25% patients were between 41-50 years and remaining 3% were 
above 70 years. 
25%
40%
32%
3%
age group
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51-60 Years
61-70 Years
Above 70 Years
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Table 2.3: 
Distribution of study subjects based on co-morbidities - [present/absent] 
 
CO-MORBIDITIES FREQUENCY PERCENT 
Absent 50 50.0 
Present 50 50.0 
Total 100 100.0 
 
Fig.2.3: 
Representation of study subjects based on presence/absence of comorbidities 
 
 
50% of the patients had no additional comorbidities other than diabetes 
mellitus. 
 
50%50%
co morbidities
Absent
Present
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Table 2.4: Distribution of study subjects based on type of co-morbidity 
(History of SHT/CAD/CKD/>1 comorbidity) 
 
CO-MORBIDITIES FREQUENCY PERCENT 
No 50 50.0 
SHT 25 25.0 
CAD 22 22.0 
Multiple comorbidities 
(+SHT/CAD/CKD combined) 
3 3.0 
Total 100 100.0 
 
Fig.2.4: Representation based on type of comorbidity 
 
25% patients had systemic hypertension, 22% had history of coronary artery 
disease, 3% had multiple comorbidities in addition to diabetes mellitus  
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Table2.5: 
 Distribution of study subjects based on type of pyelonephritis[NEPN/EPN] 
PYELONEPHRITIS FREQUENCY PERCENT 
EPN 19 19.0 
NEPN 81 81.0 
Total 100 100.0 
 
Fig.2.5: Representation based on type of pyelonephritis 
 
 
Out of the 100 patients admitted with acute pyelonephritis with type 2 diabetes 
mellitus, 81% patients had NEPN and 19% had EPN.  
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pyelonephritis
EPN
NEPN
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Table 2.6: Distribution of study subjects based on duration of fever 
 
  Total 
EPN NEPN 
FEVER_DAYS_ 
4-7 DAYS 
Count 2 11 13 
%  10.5% 13.6% 13.0% 
8-10 DAYS 
Count 7 31 38 
%  36.8% 38.3% 38.0% 
ABOVE 10 DAYS 
Count 10 39 49 
%  52.6% 48.1% 49.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=0.182 P= 0.913 
 
Fig.2.6: Representation of study subjects based on duration of fever 
 
At the time of admission, 49% patients had duration of fever >10 days, 38% 
had fever for 8-10 days and only 13% had fever for <7 days.  
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Table 2.7: 
Distribution of study subjects based on loin pain(present/absent) 
  Total 
EPN NEPN 
LOIN_PAIN 
N 
Count 1 14 15 
%  5.3% 17.3% 15.0% 
Y 
Count 18 67 85 
%  94.7% 82.7% 85.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=1.744  P= 0.187 
Fig.2.7: Representation based on loin pain(present/absent) 
 
Loin pain was present in 95% of patients with EPN and 83% of patients with 
NEPN. 
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Table 2.8: Distribution of study subjects based on other symptoms 
  Total 
EPN NEPN 
Other_Symptoms 
Burning 
micturition 
Count 2 23 25 
%  10.5% 28.4% 25.0% 
Decreased 
urine output 
Count 1 8 9 
%  5.3% 9.9% 9.0% 
None(N) 
Count 14 39 53 
%  73.7% 48.1% 53.0% 
Vomiting 
Count 2 11 13 
%  10.5% 13.6% 13.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=4.333 P= 0.228 
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Table 2.9:  
Distribution of study subjects based on altered sensorium(present/absent) 
  Total 
EPN NEPN 
Altered Sensorium 
N 
Count 15 79 94 
%  78.9% 97.5% 94.0% 
Y 
Count 4 2 6 
%  21.1% 2.5% 6.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=9.424*  P= 0.002 
Fig.2.9: Representation based on presence of altered sensorium 
 
Altered sensorium was seen in 21% of EPN and 2% of NEPN patients. 
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Table 2.10:Distribution of study subjects based on shock 
(present/absent) 
  Total 
EPN NEPN 
Shock 
N 
Count 12 77 89 
%  63.2% 95.1% 89.0% 
Y 
Count 7 4 11 
%  36.8% 4.9% 11.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=16.001**  P< 0.001 
Fig.2.10: Representation based on presence of shock 
 
Shock was present on admission in 37% of EPN and 5% of NEPN patients. 
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Table 2.11:Distribution of study subjects based on  HUN (present/absent) 
   Total 
EPN NEPN 
HUN side 
N 
Count 17 63 80 
  %  89.5% 77.8% 80.0% 
  
Y 
Count 2 18 20 
  %  10.5% 22.2% 4.0% 
Total 
Count 19 81 100 
%  
100.00
% 100.00% 
100.00
% 
Pearson Chi-Square=1.316    P=0.251 
 
Fig.2.11: Representation based on presence of HUN 
 
HUN was present in 10% of EPN and 22% of NEPN patients 
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Table 2.12: Summary of findings in CECT-KUB 
 
 
 
Total EPN NEPN 
CECT 
KUB 
Class 1 Count 3 0 3 
%  15.8% .0% 3.0% 
Class 2 Count 7 0 7 
%  36.8% .0% 7.0% 
Class 3A Count 3 0 3 
%  15.8% .0% 3.0% 
Class 3B Count 2 0 2 
%  10.5% .0% 2.0% 
Class 4 Count 2 0 2 
%  10.5% .0% 2.0% 
ND Count 2 78 80 
%  10.5% 96.3% 80.0% 
PUJ calculus 2*1cm Count 0 1 1 
%  .0% 1.2% 1.0% 
PUJ calculus 2*2cm Count 0 1 1 
%  .0% 1.2% 1.0% 
RT.Renal 
abscess(2*2cm) 
Count 0 1 1 
%  .0% 1.2% 1.0% 
Total Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=87.329** P<0.0001 
 
 
 
56 
 
Fig.2.12: Representation of the findings in CECT-KUB 
 
 
 
 
According to CECT-KUB, patients with EPN categorized. 15.8% belonged to 
class 1, 36.8% belonged to class 2, 15.8% belonged to class 3A, 10.5% 
belonged to class 3B, 2% belonged to class 4. PUJ calculi seen in 2% patients 
and renal abscess in 1%. 
 
 
 
 
 
 
 
0%
20%
40%
60%
80%
100%
16%
37%
16%
10% 11% 10%
0% 0% 0%
0% 0% 0% 0% 0%
96%
1% 1% 2%
EPN
NEPN
57 
 
Table 2.13: Distribution of study subjects based on class of EPN  
 EPN 
   CLASS 
Class 1 
Count 3 
%  15.8% 
Class 2 
Count 7 
%  36.8% 
Class 3A 
Count 3 
%  15.8% 
Class 3B 
Count 2 
%  10.5% 
Class 4 
Count 2 
%  10.5% 
 
ND 
Count 2 
 %  10.5% 
 TOTAL  19 
 
                              Fig.2.13: Representation of class of EPN 
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 Table 2.14:Distribution of study subjects based on HBA1C  
  Total 
EPN NEPN 
hba1c group 
6.5-7.0 
Count 0 50 50 
%  0.0% 61.7% 50.0% 
7.01-7.50 
Count 2 26 28 
%  10.5% 32.1% 28.0% 
Above 7.50 
Count 17 5 22 
%  89.5% 6.2% 22.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=62.828** P<0.0001 
                      
                             Fig.2.14: Representation based on HBA1C 
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Table 2.15:Distribution of study subjects based on serum 
creatinine.(normal, Increased) 
  Total 
EPN NEPN 
SR_CR 
NORMAL 
Count 3 51 54 
%  15.8% 63.0% 54.0% 
INCREASED 
Count 16 30 46 
%  84.2% 37.0% 46.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=13.787** P<0.0001 
               Fig.2.15: Representation based on serum creatinine levels 
 
Serum creatinine was increased in 84% of EPN and 37% of NEPN patients. 
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                                                   Table 2.16: 
Distribution of study subjects based on urine culture organisms in NEPN 
 
 
NEPN 
Count 
Column N 
% 
Urine_C/S Acinetobacter 6 7.4% 
Candida albicans 2 2.5% 
Candida non-
albicans 
1 1.2% 
E.coli 46 56.8% 
Klebsiella 1 1.2% 
No growth 14 17.3% 
Polymicrobial 10 12.3% 
Pseudomonas 1 1.2% 
 
                   Fig.2.16: Representation based on organisms in NEPN 
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                                             Table 2.17: 
Distribution of study subjects based on urine culture organisms in EPN 
 
EPN 
Count 
Column N 
% 
Urine_C/S Acinetobacter 1 5.3% 
Candida albicans 0 .0% 
Candida non-
albicans 
0 .0% 
E.coli 12 63.2% 
Klebsiella 2 10.5% 
No growth 1 5.3% 
Polymicrobial 3 15.8% 
Pseudomonas 0 .0% 
                    
                    Fig.2.17:  Representation based on organisms in EPN 
Pearson Chi-Square=7.199   P= 0.499 
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Table 2.18: 
Comparison of urine culture in EPN and NEPN 
 Total 
EPN NEPN 
Urine_C/S 
Acinetobacter 
Count 1 6 7 
%  5.3% 7.4% 7.0% 
Candida albicans 
Count 0 2 2 
%  0.0% 2.5% 2.0% 
Candida non-albicans 
Count 0 1 1 
%  0.0% 1.2% 1.0% 
E.coli 
Count 12 46 58 
%  63.2% 56.8% 58.0% 
Klebsiella 
Count 2 1 3 
%  10.5% 1.2% 3.0% 
No growh 
Count 1 14 15 
%  5.3% 17.3% 15.0% 
Polymicrobial 
Count 3 10 13 
%  15.8% 12.3% 13.0% 
Pseudomonas 
Count 0 1 1 
%  0.0% 1.2% 1.0% 
Total 
Count 19 81 100 
%  100.0% 100.0% 100.0% 
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Fig.2.18: Representation of comparison of urine culture in  
                 EPN (series 1) and NEPN (series 2)
 
In patients with EPN, 63.2% of the cultures were positive for E.coli, 15.8% 
positive for multiple organisms (polymicrobial), 10.5% cultures were positive 
for Klebsiella, 5.3% cultures had no growth and 5.3% of the cultures were 
positive for Acinetobacter species. 
In patients with NEPN, 56.8% cultures positive for Escherichia coli, no growth 
in culture seen in 17.3% cases, 12.3% cultures positive for multiple organisms 
(polymicrobial), 7.4% cultures positive for Acinetobacter, 2.5% of the cultures 
positive for Candida albicans, 1.2% cultures positive for Candida non-albicans, 
1.2% of the cultures positive for Klebsiella and 1.2% cultures were positive for 
Pseudomonas. 
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Table 2.19: Distribution of study subjects based on Treatment other than i.v.           
antibiotics in NEPN and EPN. 
 EPN NEPN TOTAL 
Treatment Other 
Than IV Antibiotics 
 DJ stent(RT) Count 0 1 1 
%  .0% 1.2% 1.0% 
Anti-fungals Count 0 3 3 
%  .0% 3.7% 3.0% 
DJ stent(B/L) Count 0 4 4 
%  .0% 4.9% 4.0% 
DJ stent(LT) Count 0 4 4 
%  .0% 4.9% 4.0% 
DJ stent(RT) Count 0 6 6 
%  .0% 7.4% 6.0% 
HD Count 0 4 4 
%  .0% 4.9% 4.0% 
N Count 9 57 66 
%  47.4% 70.4% 66.0% 
Nephrectomy(RT) Count 1 0 1 
%  5.3% .0% 1.0% 
PCN(LT) Count 4 0 4 
%  21.1% .0% 4.0% 
PCN(RT) Count 5 0 5 
%  26.3% .0% 5.0% 
URSL(LT)+DJ stent Count 0 1 1 
%  .0% 1.2% 1.0% 
URSL(RT)+DJ stent Count 0 1 1 
%  .0% 1.2% 1.0% 
Total Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson chi square =49.495**p<0.001 
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Fig.2.19: Representation of treatment given other than I.V.antibiotics 
 
In patients with NEPN, only antibiotics were used for treatment in 70% 
patients, in addition to antibiotics 37% patients were treated with anti-fungals, 
for 17.2% patients DJ stenting was done, HD was done for 4.9% patients and 
URSL+DJ stenting done for 2.4% patients. 
 
In patients with EPN, PCN was done for 47.7% patients, nephrectomy done in 
5.3% patients and antibiotics along with supportive medical management alone 
given for 47.4% patients 
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Table 2.20: Treatment outcomes in NEPN and EPN  
 
 EPN NEPN TOTAL 
Outcome1 Death Count 10 1 11 
%  52.6% 1.2% 11.0% 
Survive
d 
Count 9 80 89 
%  47.4% 98.8% 89.0% 
Total Count 19 81 100 
%  100.0% 100.0% 100.0% 
Pearson Chi-Square=41.527**p<0.001 
Fig.2.20: Treatment outcomes in NEPN and EPN 
 
99% of NEPN group survived while only 47% of EPN group survived.  
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Table 2.21: Outcome of EPN and NEPN based on treatment ( good= 
successfully treated with antibiotics/PCN....Poor=patients who expired / had 
nephrectomy] 
 
  
EPN NEPN 
Count 
Column 
N % Count 
Column 
N % 
Treatment Anti-fungals Death 0 .0% 0 .0% 
Survived 0 .0% 3 100.0% 
DJ stent Death 0 .0% 0 .0% 
Survived 0 .0% 15 100.0% 
HD Death 0 .0% 0 .0% 
Survived 0 .0% 4 100.0% 
N Death 7 77.8% 1 1.8% 
Survived 2 22.2% 56 98.2% 
Nephrectomy Death 0 .0% 0 .0% 
Survived 1 100.0% 0 .0% 
PCN Death 2 22.2% 0 .0% 
Survived 7 77.8% 0 .0% 
URSL+DJ 
stent 
Death 0 .0% 0 .0% 
Survived 0 .0% 2 100.0% 
 
 
68 
 
                                              Table 2.22:  
Comparison of prognostic indicators of good and poor outcomes in EPN and 
NEPN. (Variables -HBA1C>7.5, ALTERED SENSORIUM, SHOCK, RENAL 
DYSFUNCTION (increased creatinine), need for HD). 
 
              Fig.2.22.Outcomes based on raised serum creatinine levels 
 
.Patients presenting with raised serum creatinine levels had poor outcomes, 
with p value<0.0001, which was statistically significant. 
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1 100% 29 
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                 Table 2.23: Outcomes in patients with HBA1C >7.5 
      
 
 
 
 
 
 
 
 
 
        Fig.2.24: Representation of outcomes in patients with HBA1C >7.5 
 
.HBA1c >7.5 was associated with poor outcome and it was statistically 
significant. P value<0.001. 
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                          Table.2.25: Outcomes in patients with shock 
EPN (n=19) NEPN (n=81) 
Poor outcome 
(n=10) 
Good 
Outcome 
(n=9) 
Poor outcome 
(n=1) 
Good Outcome 
(n=80) 
SHOCK (n=7) SHOCK (n=4) 
N % N % N % N % 
7 100% 0 0% 1 25% 3 75% 
 
     Fig.2.25: Representation of outcomes in patients with shock 
 
Patients presenting with shock on admission had poor outcome, with p 
value<0.001, which was statistically significant. 
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               Table 2.26: Outcomes in patients with altered sensorium 
EPN (n=19) NEPN (n=81) 
Poor 
outcome(n=10) 
Good 
Outcome(n=9) 
Poor 
outcome(n=1) 
Good 
Outcome(n=80) 
Altered sensorium (n=4) Altered sensorium (n=2) 
N % N % N % N % 
3 75% 1 25% 1 50% 1 50% 
 
 
Fig.2.26: Representation of outcomes in patients with altered sensorium 
 
Patients presenting with altered sensorium on admission had poor 
outcome with p value = 0.002, which was statistically significant.  
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DISCUSSION 
During the study period, out of the 100 patients admitted with acute 
pyelonephritis with type 2 diabetes mellitus, 81% patients had NEPN and 19% 
had EPN. 
Renal abscess was seen in only 1% of the patients. 
48 patients were males and 52 were females. 
Around 40% patients were in the age group of 51-60 years, 32% were 
between 61-70 years, 25% patients were between 41-50 years and remaining 
3% were above 70 years. 
50% of the patients had no additional comorbidities other than diabetes 
mellitus. 
25% patients had systemic hypertension, 22% had coronary artery 
disease, 3% had multiple comorbidities in addition to diabetes mellitus. 
At the time of admission, 49% patients had duration of fever >10 days, 
38% had fever for 8-10 days and only 13% had fever for <7 days. 
85% of patients had loin pain on admission. Of that, 82.7% of patients 
with NEPN and 94.7 patients of EPN had loin pain. 
Other symptoms including burning micturition was present in 25% of 
patients, decreased urine output was seen in 9% of patients and history of 
vomiting was present in 13% of patients. 
Altered sensorium at the time of admission was present in 6% of 
patients. Of that, 21.1% patients with EPN had altered sensorium on admission, 
while only 2.5% patients with NEPN had altered sensorium. Patients presenting 
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with altered sensorium on admission had poor outcome with p value = 0.002, 
which was statistically significant. 
Patients presenting with shock at the time of admission was 11%. Of 
that, 38.6% patients with EPN presented with shock while only 4.9% patients 
with NEPN presented with shock on admission. Patients presenting with shock 
on admission had poor outcome, with p value<0.001, which was statistically 
significant. 
About 54% of the patients had normal serum creatinine levels and 46% 
had raised serum creatinine levels at the time of admission. Of that, 52.6% 
patients with EPN had raised serum creatinine levels while only 37% patients 
with NEPN had raised serum creatinine levels. Patients presenting with raised 
serum creatinine levels had poor outcomes, with p value<0.0001, which was 
statistically significant. 
About 50% patients had HBA1C in the range of 6.5-7.0, 28% had 
HBA1C of 7.01-7.5, and 22% had HBA1C >7.5.In the EPN group, 17 out of 19 
patients had HBA1C >7.5 while it was seen in only 5 out of 81 patients in 
NEPN group. HBA1c >7.5 was associated with poor outcome and it was 
statistically significant. P value<0.001. 
On Ultrasound KUB, hydroureteronephrosis present in 22.2% patients 
with NEPN and 10.5% patients with EPN. PUJ calculus was found in 2 
patients. 
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According to CECT-KUB, patients with EPN categorized. 15.8% 
belonged to class 1, 36.8% belonged to class 2, 15.8% belonged to class 3A, 
10.5% belonged to class 3B, 2% belonged to class 4. 
CECT-KUB could not be done in 2% of patients with EPN due to early 
mortality at the time of admission. 
In patients with NEPN, 56.8% cultures positive for Escherichia coli, no 
growth in culture seen in 17.3% cases, 12.3% cultures positive for multiple 
organisms (polymicrobial), 7.4% cultures positive for Acinetobacter, 2.5% of 
the cultures positive for Candida albicans, 1.2% cultures positive for Candida 
non-albicans, 1.2% of the cultures positive for Klebsiella and 1.2% cultures 
were positive for Pseudomonas. 
In patients with EPN, 63.2% of the cultures were positive for E.coli, 
15.8% positive for multiple organisms (polymicrobial), 10.5% cultures were 
positive for Klebsiella, 5.3% cultures had no growth and 5.3% of the cultures 
were positive for Acinetobacter species. 
In patients with NEPN, only antibiotics were used for treatment in 70% 
patients, in addition to antibiotics 37% patients were treated with anti-fungals, 
for 17.2% patients DJ stenting was done, HD was done for 4.9% patients and 
URSL+DJ stenting done for 2.4% patients. 
In patients with EPN, PCN was done for 47.7% patients, nephrectomy 
done in 5.3% patients and antibiotics along with supportive medical 
management alone given for 47.4% patients. 
           99% of NEPN group survived while only 47% OF EPN group survived. 
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CONCLUSION 
 
 A high index of suspicion and early imaging studies are required 
to diagnose EPN in diabetics presenting with features of 
pyelonephritis, especially if blood sugars are poorly controlled. 
 
 Majority of the patients were in the age group of 51-70 years. 
 
 Majority of cases with both NEPN and EPN were found to be due 
to gram negative bacteria. 
 
 EPN patients with Class I, II and IIIA can be managed 
successfully with either antibiotics or with additional PCN. Class 
IIIB and IV may need nephrectomy. 
 
 Patients presenting with altered sensorium and shock at 
presentation portend poor prognosis. 
 
 Pyelonephritis in diabetics may be associated with renal failure 
and a high mortality rate. 
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LIMITATIONS OF STUDY 
 
- Single centre study. 
- Being a tertiary care referral centre, the results might not be true 
representation of the population. 
- Longer follow up could not be obtained. 
- The recurrence rate of the disease could not be assessed. 
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A STUDY ON CLINICAL, MICROBIAL PROFILE, PROGNOSTIC 
FACTORS AND TREATMENT OUTCOME IN PATIENTS OF ACUTE 
PYELONEPHRITIS  WITH TYPE 2 DIABETES MELLITUS 
Name  : 
Age/Sex : 
OP/IP No : 
Occupation : 
Address : 
Contact No. : 
SYMPTOMS 
• Fever 
• Chills and rigors 
• Loin pain 
• Dysuria 
• Nausea and vomiting 
PATIENT CHARACTERISTICS 
• Age 
• sex 
• pregnancy status 
EXAMINATION 
• Temperature 
• Loin tenderness 
INVESTIGATIONS 
CBC 
SERUM CREATININE 
FBS 
PPBS 
URINE COMPLETE EXAMINATION WITH C/S 
HbA1c 
USG-KUB (Baseline) 
CECT-KUB (When necessary) 
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                          INFORMATION SHEET 
We are conducting a study on “A STUDY ON CLINICAL, MICROBIAL 
PROFILE, PROGNOSTIC FACTORS AND TREATMENT OUTCOME 
OF ACUTE PYELONEPHRITIS IN PATIENTS WITH TYPE 2  
DIABETES MELLITUS ” among patients attending Rajiv  Gandhi 
Government General Hospital, Chennai.  
The purpose of this study is to analyse the clinical features, 
microbiological profile , prognostic factors and treatment outcome of 
pyelonephritis in diabetic patients. 
The privacy of the patients in the research will be maintained throughout 
the study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
The results of the special study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which may aid 
in the management or treatment. 
 
Signature of Investigator 
  
Signature of Participant 
 
Date   : 
Place  : 
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                              PATIENT CONSENT FORM 
 
Study Detail : A STUDY ON CLINICAL, MICROBIAL 
PROFILE, PROGNOSTIC FACTORS AND 
TREATMENT OUTCOME IN PATIENTS OF 
ACUTE PYELONEPHRITIS  WITH TYPE 2 
DIABETES MELLITUS 
Study Centre : Rajiv Gandhi Government General Hospital, 
Chennai. 
Patient’s Name :  
Patient’s Age :  
Identification 
Number 
:  
Patient may check (☑) these boxes 
I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask question and all my questions and 
doubts have been answered to my complete satisfaction.  
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal 
rights being affected.  
I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in 
respect of current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree to 
this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any 
data or results that arise from this study.  
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team 
and to immediately inform the study staff if I suffer from any 
deterioration in my health or well being or any unexpected or unusual 
symptoms.  
I hereby consent to participate in this study.  
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological 
tests.  
 
Signature/thumb impression:                                 Signature of Investigator 
                                                                                  DR.S.KARTHIKAA 
Patient’s Name and Address: 
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